Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy.
Bastola S, Pavlyukov MS, Yamashita D, Ghosh S, Cho H, Kagaya N, Zhang Z, Minata M, Lee Y, Sadahiro H, Yamaguchi S, Komarova S, Yang E, Markert J, Nabors LB, Bhat K, Lee J, Chen Q, Crossman DK, Shin-Ya K, Nam DH, Nakano I. Bastola S, et al. Among authors: nabors lb. Nat Commun. 2020 Sep 16;11(1):4660. doi: 10.1038/s41467-020-18189-y. Nat Commun. 2020. PMID: 32938908 Free PMC article.
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
Patel DM, Foreman PM, Nabors LB, Riley KO, Gillespie GY, Markert JM. Patel DM, et al. Among authors: nabors lb. Hum Gene Ther Clin Dev. 2016 Jun;27(2):69-78. doi: 10.1089/humc.2016.031. Hum Gene Ther Clin Dev. 2016. PMID: 27314913 Free PMC article. Clinical Trial.
Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors.
Filippova N, Yang X, Ananthan S, Calano J, Pathak V, Bratton L, Vekariya RH, Zhang S, Ofori E, Hayward EN, Namkoong D, Crossman DK, Crowley MR, King PH, Mobley J, Nabors LB. Filippova N, et al. Among authors: nabors lb. Cancer Res. 2021 Apr 15;81(8):2220-2233. doi: 10.1158/0008-5472.CAN-20-2858. Epub 2021 Feb 18. Cancer Res. 2021. PMID: 33602784 Free PMC article.
Targeting the TREM1-positive myeloid microenvironment in glioblastoma.
Filippova N, Grimes JM, Leavenworth JW, Namkoong D, Yang X, King PH, Crowley M, Crossman DK, Nabors LB. Filippova N, et al. Among authors: nabors lb. Neurooncol Adv. 2022 Sep 15;4(1):vdac149. doi: 10.1093/noajnl/vdac149. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36249290 Free PMC article.
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.
Markert JM, Razdan SN, Kuo HC, Cantor A, Knoll A, Karrasch M, Nabors LB, Markiewicz M, Agee BS, Coleman JM, Lakeman AD, Palmer CA, Parker JN, Whitley RJ, Weichselbaum RR, Fiveash JB, Gillespie GY. Markert JM, et al. Among authors: nabors lb. Mol Ther. 2014 May;22(5):1048-55. doi: 10.1038/mt.2014.22. Epub 2014 Feb 27. Mol Ther. 2014. PMID: 24572293 Free PMC article. Clinical Trial.
The role of Src family kinases in growth and migration of glioma stem cells.
Han X, Zhang W, Yang X, Wheeler CG, Langford CP, Wu L, Filippova N, Friedman GK, Ding Q, Fathallah-Shaykh HM, Gillespie GY, Nabors LB. Han X, et al. Among authors: nabors lb. Int J Oncol. 2014 Jul;45(1):302-10. doi: 10.3892/ijo.2014.2432. Epub 2014 May 9. Int J Oncol. 2014. PMID: 24819299 Free PMC article.
Implementation and utilization of the molecular tumor board to guide precision medicine.
Harada S, Arend R, Dai Q, Levesque JA, Winokur TS, Guo R, Heslin MJ, Nabell L, Nabors LB, Limdi NA, Roth KA, Partridge EE, Siegal GP, Yang ES. Harada S, et al. Among authors: nabors lb. Oncotarget. 2017 Jun 14;8(34):57845-57854. doi: 10.18632/oncotarget.18471. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915716 Free PMC article. Review.
175 results